Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses
Cell Proliferation · 2023-02 · 56 (2)
DOI: 10.1111/cpr.13354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 20.10.2022. Verfasst von Xiaowei Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, Shenyan…. Hauptthemen laut MEDLINE: Spina Bifida Cystica, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 345 Talent Project, National Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Spina bifida aperta (SBA) is one of the most common neural tube defects. Neural injury in SBA occurs in two stages involving failed neural tube closure and progressive degeneration through contact with the amniotic fluid. We previously suggested that intra‐amniotic bone marrow‐derived mesenchymal stem cell (BMSC) therapy for fetal rat SBA could achieve beneficial functional recovery through lesion‐specific differentiation. The aim of this study is to examine whether the amniotic fluid microenvironment can be improved by intra‐amniotic BMSC transplantation.
Methods
The intra‐amniotic BMSC injection was performed using in vivo rat fetal SBA models. The various cytokine expressions in rat amniotic fluid were screened by protein microassays. Intervention experiments were used to study the function of differentially expressed cytokines.
Results
A total of 32 cytokines showed significant upregulated expression in the BMSC‐injected amniotic fluid. We focused on Activin A, NGF, BDNF, CNTF, and CXCR4. Intervention experiments showed that the upregulated Activin A, NGF, BDNF, and CNTF could inhibit apoptosis and promote synaptic development in fetal spinal cords. Inhibiting the activity of these factors weakened the anti‐apoptotic and pro‐differentiation effects of transplanted BMSCs. Inhibition of CXCR4 activity reduced the engraftment rate of BMSCs in SBA fetuses.
Conclusion
BMSC transplantation can improve the amniotic fluid environment, and this is beneficial for SBA repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China.
- Department of Pediatric Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China.
ORCID-Profile: Xiaowei Wei
Förderung
- 345 Talent Project
- National Key Research and Development Program
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wei, X., Ma, W., Gu, H., Liu, D., Luo, W., Cao, S., Jia, S., Huang, T., He, Y., Bai, Y., Wang, W., & Yuan, Z. (2023). Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses. Cell Proliferation, 56(2). https://doi.org/10.1111/cpr.13354
Vancouver
Wei X, Ma W, Gu H, Liu D, Luo W, Cao S, et al. Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses. Cell Proliferation. 2023;56(2). doi:10.1111/cpr.13354
BibTeX
@article{Wei2023,
author = {Wei, Xiaowei and Ma, Wei and Gu, Hui and Liu, Dan and Luo, Wenting and Cao, Songying and Jia, Shanshan and Huang, Tianchu and He, Yiwen and Bai, Yuzuo and Wang, Weilin and Yuan, Zhengwei},
title = {Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {2},
doi = {10.1111/cpr.13354}
}
EUVIMED